# CORRESP — Allarity Therapeutics, Inc.  (ALLR)  (CIK 0001860657)

> <strong>Allarity Therapeutics, Inc.  (ALLR)  (CIK 0001860657) → SEC staff</strong> · filed 2025-09-30 · ticker ALLR · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001213900-25-093435
- **Form:** CORRESP
- **Filer:** Allarity Therapeutics, Inc.  (ALLR)  (CIK 0001860657)
- **CIK:** 0001860657
- **Ticker:** ALLR
- **Filed:** 2025-09-30
- **SIC industry:** 2834
- **HQ:** Boston, MA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1860657/000121390025093435/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1860657&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Allarity Therapeutics, Inc.  (ALLR)  (CIK 0001860657)

- CORRESP — 2026-04-22 — /comment-letter/0001213900-26-046485
- UPLOAD — 2025-09-29 — /comment-letter/0000000000-25-010628

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Allarity Therapeutics, Inc.  (ALLR)  (CIK 0001860657) (CIK 0001860657), filed 2025-09-30, accession 0001213900-25-093435. Retrieved via MORVS 2026-11-19 from https://api.morvs.ai/comment-letter/0001213900-25-093435.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*
